CRISIS, PRECRISIS AND DRUG RESISTANCE IN MYASTHENIA GRAVIS*
1966; Wiley; Volume: 135; Issue: 1 Linguagem: Inglês
10.1111/j.1749-6632.1966.tb45481.x
ISSN1749-6632
Autores Tópico(s)Myasthenia Gravis and Thymoma
ResumoAnnals of the New York Academy of SciencesVolume 135, Issue 1 p. 335-345 CRISIS, PRECRISIS AND DRUG RESISTANCE IN MYASTHENIA GRAVIS* Gilbert H. Glaser, Gilbert H. Glaser Section of Neurology, Department of Medicine, Yale University School of Medicine, New Haven, Conn.Search for more papers by this author Gilbert H. Glaser, Gilbert H. Glaser Section of Neurology, Department of Medicine, Yale University School of Medicine, New Haven, Conn.Search for more papers by this author First published: January 1966 https://doi.org/10.1111/j.1749-6632.1966.tb45481.xCitations: 16 * Aided by grants from The Myasthenia Gravis Foundation. AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL References ARANOW, H., P. F. A. HOEFER & L. P. ROWLAND 1957. The long-acting anti-cholinesterase drugs in the management of myasthenia gravis. J. Chron. Dis. 6: 457– 474. AXELSSON, J. & S. THESLEFF 1958. The “desensitizing” effect of acetylcholine on the mammalian motor end-plate. Acta Physiol. Scand. 43: 15– 26. BARRNETT, R. J. 1962. The fine structural localization of acetylcholinesterase at the myoneural junction. J. Cell. Biol. 12: 247– 262. BICKERSTAFF, E. R. & A. L. WOOLF 1960. The intramuscular nerve endings in myasthenia gravis. Brain 83: 10– 23. BICKERSTAFF, E. R., J. V. EVANS & A. L. WOOLF 1960. The ultrastructure of human myasthenic and non-myasthenic motor end-plates. Brain 83: 638– 647. CAMPBELL, H. & E. BRAMWELL 1900. Myasthenia gravis. Brain 23: 277– 337. CHURCHILL-DAVIDSON, H. C. & R. T. RICHARDSON 1953. Neuromuscular transmission in myasthenia gravis. J. Physiol. 122: 252– 263. CHURCHILL-DAVIDSON, H. C. & A. T. RICHARDSON 1961. A study of neuro-muscular transmission in one hundred cases of myasthenia sravis. In Myasthenia Gravis. H. R. Viets, Ed.: 199– 207. C. C. Thomas, Springfield , Ill . CHURCHILL-DAVIDSON, H. C. & R. P. WISE 1963. Neuromuscular transmission in the newborn infant. Anesthesiology 24: 271– 278. COERS, C. & J. E. DESMEDT 1959. Mise en évidence d'une malformation carac-téristique de la junction neuromusculaire dans la myasthenie. Acta Neurol. Psychiat. Belg. 59: 539– 561. COHEX. R. R & S. I. ZACKS 1959. Myasthenia gravis II. Histochemical demonstration of acetylcholinesterase activity in motor end-plates of extraocnlar muscle in patients with myasthenia gravis. A post-mortem study. Am. J. Path. 35: 399– 405. COERS, C. & A. I. WOOLF 1959. The Innervation of Muscle. Blackwell, Oxford , England . DAHLBACK, 0., D. ELMQVIST, T. R. JOHNS, S. RADNER & S. THESLEFF 1961. An electrophysiological study of the neuromuscular junction in myasthenia gravis. J. Physiol. 156: 336– 343. DESMEDT, J. E. 1961. Neuromuscular defect in myasthenia gravis: electrophysiological and histopathological evidence. In Myasthenia Gravis. H. R. Viets, Ed.: 150– 178. C. C. Thomas, Springfield , Ill . DESMEDT, J. E. 1962. Donnees recentes sur la pathogenic de la myasthenie grave. Bull. Acad. roy. Med. Belg. VII Serie. 2: 213– 267. EATON, L. M. & E. H. LAMBERT 1957. Electromyography and electric stimulation of nerves in diseases of motor unit: Observations on myasthenie syndrome associated with malignant tumors. J.A.M.A. 163: 1117– 1124. ELMQVIST, D., W. W. HOFMANN, J. KUGELBERG & D. M. J. QUASTEL 1964. An electrophysiological investigation of neuromuscular transmission in myasthenia gravis. J. Physiol. 174: 417– 434. FENICHEL, G. & G. M. SHY 1963. Muscle biopsy experience in myasthenia gravis. Arch. Neurol. 9: 237– 243. GLASER, G. H. 1963. Pharmacological considerations in the treatment of myasthenia gravis. Adv. Pharmacol. 2: 113– 160. GROB, D. 1961. Myasthenia gravis. Arch. Int. Med. 108: 615– 638. GROB, D. R. & R. J. JOHNS 1958. Use of oximes in the treatment of intoxication by anticholinesterase compounds in patients with myasthenia gravis. Am. J. Med. 24: 512– 518. GROB, D. & R. J. JOHNS 1961. Further studies on the mechanism of the defect in neuromuscular transmission in myasthenia gravis, with particular reference to the acetylcholine-insensitive block. In Myasthenia Gravis. H. R. Viets, Ed.: 127– 129. C. C. Thomas, Springfield , Ill . GROB, D., R. J. JOHNS & A. M. HARVEY 1956. Studies in neuromuscular function. Bull. Johns%. Hopk Hosp.. 99: 115– 238. KATZ, B. & S. THESLEFF 1957. A study of the “desensitization” produced by acetylcholine at the motor end-plate. J. Physiol. 138: 63– 80. KOREY, S. R. & C. T. RANDT 1950. Treatment of myasthenie crisis. J. Nerv. Ment. Dis. 112: 445– 446. MAGDERMOT, V. 1960. The changes in the motor end plate in myasthenia gravis. Brain 83: 24– 35. OOSTERHUIS, H. J. G. H. 1964. Studies in myasthenia gravis. Part 1. A clinical study of 180 patients. J. Neurol. Sci. 1: 512– 546. OSSERMAN, K. E. 1958. Myasthenia Gravis. Grune & Stratton, New York , N. Y . OSSERMAN. K. E & G. GENKINS 1963. Studies in myasthenia gravis. Reduction in mortality rate after crisis. J.A.M.A. 183: 97– 101. PELIKAN, E. W., J. E. TETHER & K. R. UNNA 1953. Sensitivity of myasthenia gravis patients to tubocurarine and decamethonium. Neurology 3: 284– 296. RANDT, C. T. 1953. Myasthenia gravis. Med. Clin. N. Amer. 37: 535– 544. ROWLAND, L. P., ARANOW, H. & P. F. A. HOEFER 1961. Observations on the curare test in the differential diagnosis of myasthenia gravis. In Myasthenia Gravis. H. R. Viets, Ed.: 411– 434. C. C. Thomas, Springfield , Ill . ROWLAND, L. P., P. F. A. HOEFER & H. ARANOW 1960. Myasthenie syndromes. Res. Publ. Assn. Nerv. Ment. Dis. 38: 548– 600. ROWLAND, L. P., P. F. A. HOEFER, H. ARANOW & H. H. MERRITT 1956. Fatalities in myasthenia gravis. Neurology 6: 306– 326. SIMPSON, J. A. 1960. Myasthenia gravis: a new hypothesis. Scot. Med. J. 5: 419– 436. SIMPSON, J. A. 1964. Myasthenia gravis and myasthenic syndromes. In Disorders of Voluntary Muscle. J. N. Walton, Ed.: 336– 368. J. & A. Churchill, Ltd., London , England . STORM-MATHISEN, A. 1961. Myasthenia Gravis. H. Aschelhoug & Co. Oslo , Norway . STRAUSS, A. J. L., B. C. SEEGAL, K. S. HSU, P. M. BURKHOLDER, W. L. NASTUK & K. E. OSSERMAN 1960. Immunofluorescence demonstration of a muscle-binding, complement-fixing serum globulin fraction in myasthenia gravis. Proc. Soc. Exp. Biol. Med. 105: 184– 191. THESLEFF, S. 1960. Effects of motor innervation on the chemical sensitivity of skeletal muscle. Physiol. Rev. 40: 734– 752. D. SPIJK & W. LAMMERS 1957. Myasthenia crisis. Lancet 2: 94. VIETS, H. R. & R. S. SCHWAB 1960. Thymectomy for Myasthenia Gravis. C. C. Thomas, Springfield , Ill . WALKER, M. B. 1934. Treatment of myasthenia gravis with physostigmine. Lancet 1: 1200– 1201. WALKER, M. B. 1935. Case showing the effect of prostigmine in myasthenia gravis. Proc. Roy. Soc. Med. 28: 759– 761. ZACKS, S. I. 1964. The Motor End Plate. W. B. Saunders, Philadelphia , Pa . ZACKS, S. I., W. C. BAUER & J. M. BLUMBERG 1962. The fine structure of the myasthenic neuromuscular junction. J. Neuropath. Exp. Neurol. 21: 335– 347. ZAIMIS, E. 1953. Motor end-plate differences as a determining factor in the mode of action of neuromuscular blocking substances. J. Physiol. 122: 238– 246. Citing Literature Volume135, Issue1Myasthenia GravisJanuary 1966Pages 335-345 ReferencesRelatedInformation
Referência(s)